Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ABOS Acumen Pharmaceuticals Inc

Price (delayed)

$1.07

Market cap

$64.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.94

Enterprise value

$63.95M

Highlights
The company's debt fell by 3.4% YoY
The company's quick ratio has shrunk by 74% YoY but it rose by 24% QoQ
Acumen Pharmaceuticals's net income has plunged by 108% YoY and by 14% from the previous quarter
Acumen Pharmaceuticals's EPS has plunged by 83% YoY and by 13% from the previous quarter

Key stats

What are the main financial stats of ABOS
Market
Shares outstanding
60.57M
Market cap
$64.81M
Enterprise value
$63.95M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$126.61M
Net income
-$116.25M
EBIT
-$112.16M
EBITDA
-$111.98M
Free cash flow
-$102.56M
Per share
EPS
-$1.94
EPS diluted
-$1.94
Free cash flow per share
-$1.69
Book value per share
$2.57
Revenue per share
$0
TBVPS
$3.38
Balance sheet
Total assets
$204.48M
Total liabilities
$48.96M
Debt
$29.53M
Equity
$155.52M
Working capital
$135.63M
Liquidity
Debt to equity
0.19
Current ratio
8.02
Quick ratio
7.73
Net debt/EBITDA
0.01
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-46.5%
Return on equity
-58.2%
Return on invested capital
-51.7%
Return on capital employed
-60.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ABOS stock price

How has the Acumen Pharmaceuticals stock price performed over time
Intraday
2.88%
1 week
4.9%
1 month
-0.93%
1 year
-60.81%
YTD
-37.79%
QTD
-2.73%

Financial performance

How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$126.61M
Net income
-$116.25M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's net income has plunged by 108% YoY and by 14% from the previous quarter
Acumen Pharmaceuticals's operating income has shrunk by 92% YoY and by 11% QoQ

Price vs fundamentals

How does ABOS's price correlate with its fundamentals

Growth

What is Acumen Pharmaceuticals's growth rate over time

Valuation

What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.42
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has plunged by 83% YoY and by 13% from the previous quarter
The company's equity fell by 41% YoY and by 14% QoQ
The P/B is 30% less than the last 4 quarters average of 0.6

Efficiency

How efficient is Acumen Pharmaceuticals business performance
ABOS's return on equity has dropped by 154% year-on-year and by 29% since the previous quarter
ABOS's ROA has dropped by 124% year-on-year and by 24% since the previous quarter
ABOS's ROIC has plunged by 94% YoY and by 26% from the previous quarter

Dividends

What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABOS.

Financial health

How did Acumen Pharmaceuticals financials performed over time
The company's quick ratio has shrunk by 74% YoY but it rose by 24% QoQ
ABOS's current ratio has dropped by 73% year-on-year but it is up by 24% since the previous quarter
The company's debt is 81% lower than its equity
The debt to equity has soared by 58% YoY and by 19% from the previous quarter
The company's equity fell by 41% YoY and by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.